pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4471 |
Genomic Coordinates | chr8: 100382763 - 100382845 |
Description | Homo sapiens miR-4471 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |
---|---|
Mature miRNA | hsa-miR-4471 |
Sequence | 49| UGGGAACUUAGUAGAGGUUUAA |70 |
Evidence | Experimental |
Experiments | Illumina |
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | GDI1 | ||||||||||||||||||||
Synonyms | 1A, GDIL, MRX41, MRX48, OPHN2, RABGD1A, RABGDIA, XAP-4 | ||||||||||||||||||||
Description | GDP dissociation inhibitor 1 | ||||||||||||||||||||
Transcript | NM_001493 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on GDI1 | |||||||||||||||||||||
3'UTR of GDI1 (miRNA target sites are highlighted) |
>GDI1|NM_001493|3'UTR 1 TTGTGGCCGCCCCCAGCCCCTGCTGCCCCAGCCTGTGTCTGTTCTCCTCGAGGGCTCCAGCATCCTCTGCTTCCCCCACC 81 ACGTTCCCATCACCCACCTCATTGATCCACTGACCAAATCCTTAACCCTAGCGATGGCTTGGGAGATGGGGGGTTGGATA 161 GCATCCTCTTTCTTGGCCCTTCCTTATCCTAGGAAAAGAGGGTTCCTCTCCTTGTGTGTGTCTCTTCCCCCCACCCCTAA 241 TTCTTCTGCTCTGTTTGGGAAGACGTGGAGGAAAAGGTGACTTCTGCCCCCACCGCTCTTACCCCCACTGTAGTGGCCTT 321 TGGAGATGCCCCCACCTCCCCCCCACCAACTCTCGCGTGTTGGAGAGAAGGGGCCCTCCCAGCACAAAGTTGCATTCCTC 401 CCCCCTAATTTATTCTAATTTATTAACTTTGACCCACCCTTTCTGAGCCTGCAGCCTTCCCGTGTGGCCTGAGGGCTGTC 481 GAGTGAGCTGCCCCAGCCCCTCCCAGCCCTTGCCCAGCCTGGGGGAGTGGGGAAGGCTTGGGCATGGCCCCGTTGGAGGT 561 TGATTTGCTGTTTTGTTTCTTGTCTTTGTGTTCTGTGGTACTTGCTGAGAGAAAAGAAAAGTGAGCCAAGCAGAAGGAGG 641 TGGGAAAACGGACCCAAACCCCAGTGTGCCCTGCCCCATGCCTTTCCTTTAGTGGTGGGAAACCCTTATCTTGCAAAGTG 721 AATGTGTCCCCTTCCCCACCCTCTAGTGTATTTCACAGAAAACAAAACCTCCCAATAAAACGGTTGAAACCTGAAAAAAA 801 AAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 2664.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065669. RNA binding protein: AGO1. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
CLIP-seq Support 1 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_001493 | 3UTR | CCAUCACCCACCUCAUUGAUCCACUGACCAAAUCCUUAACCCUAGCGAUGGCUUGGGAGAUGGGGGGUUGGAUAGCAUCCUCUUUCUUGGCCCUUCCUUAUCCUAGGAAAAGAGGGUUCCUCUCCUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_001493 | 3UTR | GUUCCCAUCACCCACCUCAUUGAUCCACUGACCAAAUCCUUAACCCUAGCGAUGGCUUGGGAGAUGGGGGGUUGGAUAGCAUCCUCUUUCUUGGCCCUUCCUUAUCCUAGGAAAAGAGGGUUCCUCUCCUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_001493 | 3UTR | CCCAUCACCCACCUCAUUGAUCCACUGACCAAAUCCUUAACCCUAGCGAUGGCUUGGGAGAUGGGGGGUUGGAUAGCAUCCUCUUUCUUGGCCCUUCCUUAUCCUAGGAAAAGAGGGUUCCUCUCCUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_001493 | 3UTR | CGUUCCCAUCACCCACCUCAUUGAUCCACUGACCAAAUCCUUAACCCUAGCGAUGGCUUGGGAGAUGGGGGGUUGGAUAGCAUCCUCUUUCUUGGCCCUUCCUUAUCCUAGGAAAAGAGGGUUCCUCUCCUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM1065669 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_8 |
Location of target site | ENST00000447750.2 | 3UTR | AGGGCUCCAGCAUCCUCUGCUUCCCCCACCACG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
51 hsa-miR-4471 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT082398 | HNRNPUL1 | heterogeneous nuclear ribonucleoprotein U like 1 | 2 | 4 | ||||||||
MIRT295740 | KIF3B | kinesin family member 3B | 2 | 2 | ||||||||
MIRT453005 | CCDC115 | coiled-coil domain containing 115 | 2 | 16 | ||||||||
MIRT456180 | ZDHHC6 | zinc finger DHHC-type containing 6 | 2 | 2 | ||||||||
MIRT457455 | UNC119B | unc-119 lipid binding chaperone B | 2 | 2 | ||||||||
MIRT464992 | TUBB2A | tubulin beta 2A class IIa | 2 | 10 | ||||||||
MIRT467615 | SLC7A5 | solute carrier family 7 member 5 | 2 | 2 | ||||||||
MIRT468602 | SERBP1 | SERPINE1 mRNA binding protein 1 | 2 | 2 | ||||||||
MIRT470070 | PTGES2 | prostaglandin E synthase 2 | 2 | 2 | ||||||||
MIRT470562 | POU2F1 | POU class 2 homeobox 1 | 2 | 2 | ||||||||
MIRT472274 | NFIB | nuclear factor I B | 2 | 2 | ||||||||
MIRT473471 | MCFD2 | multiple coagulation factor deficiency 2 | 2 | 2 | ||||||||
MIRT477892 | DVL3 | dishevelled segment polarity protein 3 | 2 | 4 | ||||||||
MIRT486345 | TACC2 | transforming acidic coiled-coil containing protein 2 | 2 | 6 | ||||||||
MIRT487190 | NFASC | neurofascin | 2 | 4 | ||||||||
MIRT488690 | NAT9 | N-acetyltransferase 9 (putative) | 2 | 2 | ||||||||
MIRT492106 | TAB2 | TGF-beta activated kinase 1/MAP3K7 binding protein 2 | 2 | 2 | ||||||||
MIRT495216 | DSCR3 | DSCR3 arrestin fold containing | 2 | 2 | ||||||||
MIRT495666 | TUBAL3 | tubulin alpha like 3 | 2 | 2 | ||||||||
MIRT501833 | NCOA2 | nuclear receptor coactivator 2 | 2 | 2 | ||||||||
MIRT507147 | GATAD2B | GATA zinc finger domain containing 2B | 2 | 4 | ||||||||
MIRT508522 | GDI1 | GDP dissociation inhibitor 1 | 2 | 2 | ||||||||
MIRT513839 | KCTD15 | potassium channel tetramerization domain containing 15 | 2 | 4 | ||||||||
MIRT513883 | GTF2IRD2 | GTF2I repeat domain containing 2 | 2 | 4 | ||||||||
MIRT527336 | COL18A1 | collagen type XVIII alpha 1 chain | 2 | 2 | ||||||||
MIRT537390 | FGD6 | FYVE, RhoGEF and PH domain containing 6 | 2 | 2 | ||||||||
MIRT538879 | BTBD1 | BTB domain containing 1 | 2 | 2 | ||||||||
MIRT539044 | ATXN1L | ataxin 1 like | 2 | 4 | ||||||||
MIRT554387 | SERTAD3 | SERTA domain containing 3 | 2 | 2 | ||||||||
MIRT554936 | RAP1A | RAP1A, member of RAS oncogene family | 2 | 2 | ||||||||
MIRT567517 | FOXC1 | forkhead box C1 | 2 | 2 | ||||||||
MIRT573598 | CERS1 | ceramide synthase 1 | 2 | 2 | ||||||||
MIRT642417 | CILP2 | cartilage intermediate layer protein 2 | 2 | 2 | ||||||||
MIRT643296 | PHKG1 | phosphorylase kinase catalytic subunit gamma 1 | 2 | 2 | ||||||||
MIRT652883 | SYVN1 | synoviolin 1 | 2 | 2 | ||||||||
MIRT657928 | GATSL2 | cytosolic arginine sensor for mTORC1 subunit 2 | 2 | 2 | ||||||||
MIRT660302 | BHLHE40 | basic helix-loop-helix family member e40 | 2 | 2 | ||||||||
MIRT664717 | SLC7A6OS | solute carrier family 7 member 6 opposite strand | 2 | 2 | ||||||||
MIRT698889 | SPTBN2 | spectrin beta, non-erythrocytic 2 | 2 | 2 | ||||||||
MIRT702007 | MIDN | midnolin | 2 | 2 | ||||||||
MIRT706808 | APOL4 | apolipoprotein L4 | 2 | 2 | ||||||||
MIRT708330 | DERL2 | derlin 2 | 2 | 2 | ||||||||
MIRT709885 | ERCC6L | ERCC excision repair 6 like, spindle assembly checkpoint helicase | 2 | 2 | ||||||||
MIRT711887 | INSIG2 | insulin induced gene 2 | 2 | 2 | ||||||||
MIRT711956 | CYP27B1 | cytochrome P450 family 27 subfamily B member 1 | 2 | 2 | ||||||||
MIRT715081 | PRKAB2 | protein kinase AMP-activated non-catalytic subunit beta 2 | 2 | 2 | ||||||||
MIRT716218 | TRIM17 | tripartite motif containing 17 | 2 | 2 | ||||||||
MIRT718124 | CHST4 | carbohydrate sulfotransferase 4 | 2 | 2 | ||||||||
MIRT718725 | VWA9 | integrator complex subunit 14 | 2 | 2 | ||||||||
MIRT719450 | APBA1 | amyloid beta precursor protein binding family A member 1 | 2 | 2 | ||||||||
MIRT725666 | ABI2 | abl interactor 2 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|